Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Events
Sections
Divisions
Staff
Dr. Carolyn M. Hutter was the director of the Division of Genome Sciences at the National Human Genome Research Institute.
… NIH in 2012, serving as a program director in the National Cancer Institute (NCI) Epidemiology and Genomics Research … a program director, serving as the NHGRI team lead for The Cancer Genome Atlas (TCGA) . Prior to NIH, she was a senior staff scientist at the Fred Hutchinson Cancer Research Center and lecturer at the University of …
Educational Resources
A retrovirus is a virus that uses RNA as its genetic material.
… material. … Acquired Immunodeficiency Syndrome (AIDS), Cancer, Cell, Deoxyribonucleic Acid (DNA), Genome, … associated with diseases, including AIDS and some forms of cancer. … A retrovirus is a virus that uses RNA as its …
News Release
NHGRI appointed Carolyn Hutter, Ph.D., director of the Division of Genome Sciences, which researches human genome function in health and disease.
… research programs. Most recently, she co-managed The Cancer Genome Atlas (TCGA) - a collaboration between NHGRI and the National Cancer Institute (NCI) - which generated over 2.5 petabytes of publically available genomic data used by the cancer research community to improve the prevention, …
Outreach
15 examples of how genomics has and continues to transform our world in myriad ways.
… Complete Genome Sequence, Genomics Impact On Society, Cancer Genomics, Genomic Testing, Enhanced Forensics, Genome …
Research at NHGRI
Families Sharing Health Assessment and Risk Evaluation (SHARE) helps you and your family learn how your family health history affects your risk for diseases.
… Colorectal Cancer Breast Cancer Prostate Cancer Type 2 Diabetes Heart … guidelines to reduce risk of heart disease, diabetes, breast cancer, and colorectal cancer . BMC Public Health, …
Clinical Research
The CLINSEQ® Study seeks to learn about the role that your genes play in your health.
… to a variety of conditions, including heart disease, breast cancer, and hearing loss. … Our goal is to enroll 1500 … Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon …
Fact Sheet
Pharmacogenomics is a growing area of genomic medicine that uses a person’s genomic information to help healthcare providers select the medications and dosages that are predicted to work best in each patient.
… testing can be used to determine if the tumor cells in a cancer patient have a specific version of a receptor, which … the choice of treatment. For example, some patients have breast cancers containing a receptor called HER2, which is called HER2-positive breast cancer. HER2 receptors can cause the cancer to grow …
Event
On April 25, 2024, National DNA Day, the National Institutes of Health (NIH) will welcome a new statue, “The Ladder,” celebrating DNA and children.
… painting, sculpting, photography and writing. Body image, cancer, genetics and our fragile democracy are her … her first social art project “Mamorial,” a nonprofit breast cancer initiative offering healing and awareness through art. …
News Release
The Genomics and Society: Expanding the ELSI Universe conference focused on issues arising from the ethical, legal and social implications of genomic research.
… to the genetic testing of women with family histories of breast cancer, genomics is rapidly becoming a fixture in our lives. …
Events
test
… MIT and Harvard, will present the lecture, Perspectives on Cancer Precision Medicine . Dr. Golub is a world leader in using genomics tools to understand the basis of cancer. He also pioneered the development of new cell-based approaches to drug discovery for cancer and other diseases. Golub is also the Charles A. Dana …